Author： Stintzing Sebastian Lenz Heinz-Josef
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.16, 2013-11, pp. : 2203-2220
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PI-3-Kinase Inhibitors in Colorectal Cancer
Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-01 ,pp. :
Access to resources
Recommend
Protein tyrosine kinase inhibitors in cancer treatment
By Traxler P.M.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. :
Protein kinase inhibitors in melanoma
By Eigentler Thomas K Meier Friedegund Garbe Claus
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. :
Irreversible Protein Kinase Inhibitors
Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. :